Crinetics Pharmaceuticals prices public offering at $45.95 per share By Investing.com
SWI Editorial Staff2026-01-06T21:37:43-08:00Crinetics Pharmaceuticals prices public offering at $45.95 per share
Crinetics Pharmaceuticals prices public offering at $45.95 per share
Since the abduction of Venezuelan President Nicolas Maduro by US special forces, President Donald Trump has promised US investment in the country’s underproductive oil fields. “We’re going to have our ...
Elon Musk in 2016 told fellow OpenAI founder Sam Altman that the AI lab, then one year old, should pursue a cloud computing deal with Microsoft rather than Amazon, according ...
Despite a momentary uptick in Strategy’s stock performance this week, its shares dropped again on Tuesday, continuing its declining streak over the past months. This comes after the company bought ...
Bitcoin traded near $92,000 in early Asia on Wednesday, while regional equities eased after a record start to the year and traders shifted focus back to data risk and geopolitics. ...
In brief Bitcoin has pulled back from a local high near $94,400 after a burst of selling triggered $440 million in liquidations, unwinding much of its early-2026 gains. The rally ...
Korean Stocks’ World-Beating Rally Just a Start, Investors Say - Bloomberg South Korean stocks are seeing no shortage of buy calls after leading global markets in 2025, drawing investors with ...
MSCI said it won't remove Strategy and other bitcoin- and crypto-holding firms from its indices for now, but won't count new share issuances.
Asia Morning Briefing: Bitcoin holds steady above $90K as fresh money returns to crypto News Video Consensus 2026 Data & Indices Markets Share this article By Sam Reynolds|Edited by Aoyon ...
An up-close view of a young indoor flowering legal medical marijuana cannabis bud. Tinnakorn Jorruang/Getty Images Cannabis plants are stabilized by netting inside one of eight grow rooms at Emerald ...